Day One: Tuesday, August 13, 2024 - EST/EDT (Eastern Daylight, GMT-4)
- Understand how to interpret and implement emerging global transparency reporting requirements
- Share best practices for harmonizing your global transparency operations and working with global data
- Map out international speaker programs and the potential challenges
- Hear cross-border interactions with HCP (specifically in Europe)
- Review strategies for risk management and data privacy in the global transparency landscape
- Discuss how to optimize data analytics to streamline operations
- Benchmarking with peers for international compliance
- G. Melissa Ince - Director, Global Transparency, Abbott Laboratories
- Long Nguyen - Manager, US Transparency, Abbott Laboratories
As digitalization accelerates within the life sciences sector, the importance of adaptive compliance and proactive monitoring has intensified. This interactive workshop addresses the critical intersection of digital transformation and compliance, focusing on emerging privacy concerns and changing risk environments. Through expert-led discussions and hands-on exercises, this workshop aims to empower compliance professionals with innovative strategies for navigating the complexities of a digital world. Participants will learn:
- How to implement advanced data analytics and automation to boost compliance monitoring and risk mitigation
- The importance of the integration of digital tools and AI to minimize risks and enhance operational efficiency
- How to navigate combining diverse data sets with algorithms to generate optimized compliance insights, ensuring the ability to stay ahead in managing privacy challenges and compliance risks effectively
- Jim Dawson - Vice President, Compliance Solutions, qordata
- Salman Kasbati - Chief Operating Officer, qordata Inc.
- G. Melissa Ince - Director, Global Transparency, Abbott Laboratories
- Long Nguyen - Manager, US Transparency, Abbott Laboratories
- Jim Dawson - Vice President, Compliance Solutions, qordata
- Salman Kasbati - Chief Operating Officer, qordata Inc.
- Jennifer Mac Neil - Senior Director, Compliance Operations, Eisai Inc.
- John Oroho, JD - Senior Advisor, Global Life Sciences – RLDatix Life Sciences; Of Counsel - Porzio, Bromberg & Newman, PC., RLDatix Life Sciences
Critical updates on the US transparency reporting landscape and analysis of Open Payments data.
- Veronika Peleshchuk Fradlin - Director of Division of Transparency Projects (DTP), Centers for Medicare and Medicaid Services (CMS)
- Amy Bedsaul - Open Payments Communications, Centers for Medicare & Medicaid Services (CMS)
Hear directly from the DOJ on current regulatory landscape, recent enforcement actions, and upcoming areas of focus for 2024 and beyond.
- Thomas Sullivan - Editor, Policy & Medicine
- Matthew Feeley - Deputy Chief, Civil Division, Healthcare Fraud Coordinator, USAO, Southern District of Florida, United States Department of Justice
- Updates on shifting country-specific regulation (Italy, etc.)
- Significant enforcement actions and lessons
- Conference guidelines and best practices
- Elan Schefflein - Senior Compliance Advisor, MedPro Systems, LLC
- Hear an overview of changes in the state transparency reporting landscape, and dive into any new state requirements and emerging trends
- Explore strategies to operationalize these new state laws and harmonize with existing transparency reporting processes
- Shane White - Senior Manager, Compliance, Integra LifeSciences
- Meghan Zalasky - Associate Manager, Global Transparency, RLDatix
- Gain insights into the current landscape of state legislative issues affecting the bio/pharmaceutical sector
- Explore advancements in state-level pharmaceutical transparency laws throughout the 2024 legislative cycle
- Merlin Brittenham - Assistant General Counsel, Pharmaceutical Research and Manufacturers of America (PhRMA)